The OCLC Research WorldCat Identities project is ending. The work provided valuable insight into how to mine bibliographic data for insight into the People and Organizations that create and serve as subjects library materials. The findings demonstrated the power of data mining over the world’s largest set of bibliographic metadata and highlighted the value of collaborative collective cataloging. The WorldCat Identities data has positively impacted OCLC’s work to build the WorldCat Entities application and the 150 million Person and Work descriptions accessible through it. This work will continue to build our entity ecosystem to support the future knowledge work of librarians.

The WorldCat Identities web application will be retired and shut down in the coming months and the data is no longer being updated. The most recent version of the data is from July of 2022. As OCLC continues to build out the WorldCat Entities ecosystem, please use it as a source for persistent Person identifiers.

WorldCat Identities

Lopez-Sall, Philomène (19..-....).

Works: 1 works in 1 publications in 1 language and 1 library holdings
Roles: Thesis advisor, Opponent
Publication Timeline
Most widely held works by Philomène Lopez-Sall
Drépanocytose et polymorphismes génétiques : épidémiologie, prédiction de gravité et stress-oxydant by Fatou Gueye( )

1 edition published in 2019 in French and held by 1 WorldCat member library worldwide

The primary objective of this thesis was to determine the isolated and combined effects of alpha-thalassemia, inductors polymorphisms (QTLs) of HbF and genotype G6PD in a context of natural progression of sickle cell disease (Studies 1 and 2). Study 1 was undertaken to evaluate for the first time the allelic frequencies of these modifiers genes in 301 Senegalese SS children. Unlike other African populations, the G6PD Betica Variant was predominant over the A (-) variant. In addition, 12% of our cohort had G6PD deficiency combined with no alpha-thalassemia. These patients will be favoured for the realization of a transcranial doppler. The results obtained in Study 2 allowed us to conclude that alpha thalassemia and QTLs of HbF are interdependent and should not be studied separately for accurate clinical prediction. Indeed, a combination of alpha thalassemia with at least 2 QTLs of HbF is required to significantly delay the first complication of the disease. However, a homozygous alpha thalassemia, even associated with 3 to 6 QTLs of HbF, increases the frequency of CVOs during childhood. Therefore, a heterozygous alpha-thalassemia with at least two QTL HbFs would be the most favourable genotype for the occurrence of CVOs. The second objective of this thesis was to study the interrelationships between oxidative stress and the clinical severity of the disease (Studies 3 to 4). Sickle cell disease is characterized by high oxidative stress that may explain some of the clinical manifestations. Our results showed that homozygous alpha-thalassemia appears to reduce oxidative stress, which would contribute to its protective effect on certain complications of the hemolytic sub-phenotype. In addition, patients with the least hospitalization and CVO appear to have better antioxidant defense (catalase and GPx activities increased). In Study 4 we studied 4 SNPs of oxidative stress genes (rs4880 of the SOD2 gene, rs207454 of the XO gene, rs233322 of the MPO gene and rs35652124 of the NFE2L2 gene). The rs4880 SNP would have a favourable effect on the biological level (less reticulocytosis, increased GPx activity) but without associated clinical translation. The same is true for rs233322, which is associated with greater haemolysis and oxidative stress (AOPP). On the other hand, a tendency to a protective effect of rs207454 for some complications (hospitalizations, osteonecrosis, sepsis, STA) was observed. Our work contributes to the understanding of the impact of modifiers genes in sickle cell disease. It could therefore, through a positive selection of at-risk patients, improve the management of the disease in countries where the basic treatments (hydroxyurea, transcranial doppler, blood transfusion) cannot be offered to all
Audience Level
Audience Level
  General Special  
Audience level: 0.00 (from 0.00 for Drépanocy ... to 0.00 for Drépanocy ...)

French (1)